Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery
Authors:
- Hisashi AdachiHAHisashi Adachi
- Hidehiro MatsuokaHMHidehiro Matsuoka
- Mika EnomotoMEMika Enomoto
- Akira SatohASAkira Satoh
- Asuka HinoAHAsuka Hino
- Yuji HiraiYHYuji Hirai
- Tsutomu ImaizumiTITsutomu Imaizumi
- 1 March 2007
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 191 (1) , 206-210
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Kimura Memorial Heart Foundation
This publication has 28 references indexed in Scilit:
- Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular eventsEuropean Heart Journal, 2005
- Very long chain N-3 fatty acids intake and carotid atherosclerosisAtherosclerosis, 2004
- Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine DimethylaminohydrolaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Plasma Homocysteine Levels and Atherosclerosis in JapanStroke, 2002
- NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular DiseaseAnnual Review of Medicine, 1997
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Renal Denervation Prevents Intraglomerular Platelet Aggregation and Glomerular Injury Induced by Chronic Inhibition of Nitric Oxide SynthesisNephron, 1996
- The role of nitric oxide and other endothelium-derived vasoactive substances in vascular diseaseProgress in Cardiovascular Diseases, 1995
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Ultrasonic evaluation of early carotid atherosclerosis.Stroke, 1990